Maat Pharma Archives

Best in Biotech 15 May 2023

The six most advanced microbiome players aiming for the gut

After decades of research, gut microbiome therapies are beginning to reach the market. Here are six of the companies harnessing the power of the microbiome to develop treatments derived from…

May 15, 2023 - 7 minutesmins - By Jonathan Smith

News and Trends 1 Dec 2022

FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA) today has been hailed ‘fantastic news’ by those in the microbiome field. Ferring Pharmaceutical's product…

December 1, 2022 - 6 minutesmins - By Liza Laws

Interview 14 Nov 2022

MaaT Pharma: leading the charge in microbiome therapeutics

The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business officer at the French biotech MaaT Pharma outlines the firm’s efforts to blaze a trail…

November 14, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 28 May 2021

Startup Creator Launched to Fill Europe’s Microbiome Translational Gap

With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the goal of priming the translational pump in hot areas where European academics have already made…

May 28, 2021 - 6 minutesmins - By Mark Zipkin

News and Trends 17 Dec 2020

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed the achievements of many innovative treatments for blood conditions, including…

December 17, 2020 - 6 minutesmins - By Victor Kotsev

News and Trends 1 Sep 2020

Microbiome Therapies Threatened by Covid-19 Restrictions

Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of stool samples. Though these measures are now loosening in France, key safety challenges remain for…

September 1, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 5 Feb 2020

MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost

French company MaaT Pharma has raised €18M in Series B financing that will support phase Ib and II trials of its biotherapeutic drug, which aims to restore the microbiome and…

February 5, 2020 - 3 minutesmins - By External Contributor

Best in Biotech 10 Jul 2019

The Top 10 Biotechs You’ll Find in Lyon

Lyon is one of the hotspots for biotech in Europe. Here are 10 of the most successful biotech companies in this beautiful French city. The second largest city in France…

July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

fecal transplant maat pharma fda enterobiotix

News and Trends 21 Jun 2019

Will US Fecal Transplant Death Impact European Biotech?

The death of a US patient from complications after a fecal transplant last week could have a major impact on microbiome research in Europe. The microbiome is a field with…

June 21, 2019 - 2 minutesmins - By Jonathan Smith

microbiome fecal transplant maat pharma enterobiotix

News and Trends 22 May 2019

Microbiome Companies Unite to Push for EU Regulation Reform

European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based treatments, which have the potential to treat inflammatory disease and bacterial infection. The companies will…

May 22, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 22 Jan 2019

No Guts, No Glory: How Microbiome Research is Changing Medicine

Scientists are uncovering many ways that the microorganisms that share our body can influence our health. It appears as though the human microbiome could be the key to treating all…

January 22, 2019 - 10 minutesmins - By Clara Rodríguez Fernández

maat pharma gut microbiome therapy cancer

News and Trends 4 Dec 2018

Microbiome Therapy Shows Early Promise in Cancer Patients

A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients undergoing chemotherapy has potential to improve the outcome of patients with the blood cancer acute…

December 4, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 19 Mar 2018

Could the Microbiome Treat Side Effects of Stem Cell Transplants?

MaaT Pharma, based in Lyon, has received authorization to launch a Phase II trial for its therapy, which targets the gut microbiota to treat complications from stem cell transplants. MaaT…

March 19, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 10 May 2017

Experts say the Microbiome could overtake Genetics as the Next Big Thing

Yesterday, a panel of experts at BioTrinity discussed the huge possibilities offered by the young microbiome field, which could soon overtake genetics. Scientists and investors worldwide are starting to turn…

May 10, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Infographics 5 Apr 2017

Infographic: Europe’s Best Biotechs Mining the Microbiome

We gathered the best of the best companies in Europe working on therapies from the microbiome -- here are the names you should know! Justine Braguy is pursuing a PhD at the Heinrich…

April 5, 2017 - 1 minutemin - By External Contributor

Interview 6 Feb 2017

“We want to be the Worldwide Leader in Microbiota”

Biotech entrepreneur Hervé Affagard, CEO of MaaT Pharma, tells the story behind the success of his young microbiome company. Hervé Affagard is the CEO and co-founder of a company with an…

February 6, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

maat pharma autologous microbiome therapy

News and Trends 23 Mar 2016

French Microbiome Startup Gets €10M to Start Clinical Trials

MaaT Pharma (France) has raised €10M in a series A round, which will allow it to start clinical development of its autologous therapy for imbalance of the Gut Microbiome. MaaT…

March 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiome microbiomics seventure partners

News and Trends 19 Mar 2015

The World’s First €100M Microbiome-focused Venture Fund opened in France

Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in our guts to cure people has shown more and more potential. The VC industry is…

March 19, 2015 - 3 minutesmins - By Philip Hemme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering